MAPT and Alzheimer disease: Specifically, we explored the incidence of amyloid and tau pathology in a deep‐phenotyped ALS cohort to estimate the occurrence of co‐pathology and to verify whether AD‐related mechanisms may be involved in ALS pathogenesis.